Mergers and Acquisitions Sell-side
Experience and stability you can count on
When you choose Alira Health, you’ll benefit from more than two decades of in-depth expertise. Our M&A Sell-side team specializes in serving:
- A range of companies with €5-250M valuation
- Cross-border small- and mid-cap deals
Alira Health is a FINRA (USA) and ORIAS (EU) certified firm.
Why choose Alira Health?
As our partner, you’ll also have access to Alira Health’s in-house clinical, regulatory, and market access experts to capture the full value of your assets.
Our recent projects included an advisory role in:
- A DNA testing company in its sale
- A specialized contract manufacturer of precision plastic components and devices in its acquisition
You might also be interested in:
Commercial and Vendor Due Diligence
Complete acquisition insight through market analysis, competitive landscape, strategic positioning, business plan assessment, investment evaluation and specific recommendation.Read more
Corporate Strategy Planning
Comprehensive industry evaluation and local market condition assessment along with accurate reviews of the company operations, to align your mission, values, goals and vision.Read more
Explore Transaction Advisory Services
The MedTech Conference 2022
We are pleased to share that we will be joining the MedTech Conference 2022 as sponsors and speakers! This year’s edition will have more than 100 sessions focusing on today’s hot topics.
Alira Health Secures an Additional $40M in Funding, Led by Creadev
We announced today the closing of an equity financing in which it raised gross proceeds of US$40 million. We intend to use the funds to invest in solutions that actively engage patients(...)
What You Should Know Before Choosing a Healthcare Transaction Advisory Firm
What’s most important when selecting a firm for your next transaction? Global experience, staff profiles, technical expertise? To learn more read our latest TAD Infographic.
Alira Health Strengthens Growth Strategy with $35M Funding, led by Creadev
Alira Health strengthens its growth strategy with a $35M funding, led by Creadev.
We Announce our role as Strategic Advisor to Mérieux Equity Partners and Mérieux Participations 3 for Entering the Capital of CTRS
We are pleased to announce our role as strategic advisor to Mérieux Equity Partners as they join the Series A financing round of Cell-Easy, through Mérieux’s newly established venture fund, OMX.
Alira Health as Strategic Advisor to Benvic in Acquisition Luc & Bel
We are proud to announce our role as strategic advisor to Benvic in the acquisition of Luc & Bel.
Five Key Success Factors for Managing Transactions in Full Virtual Mode
It is no secret that the COVID-19 pandemic has presented new challenges for businesses, and virtual has become the ‘new normal’, including for transactions.